Molecular Basis of the Rapamycin Insensitivity of Target Of Rapamycin Complex 2

Molecular Cell

Volumn 58, Issue 6, 2015, Pages 977-988

  Gaubitz, Christl ^a   Oliveira, Taiana M ^b,c   Prouteau, Manoel ^a   Leitner, Alexander ^d   Karuppasamy, Manikandan ^b   Konstantinidou, Georgia ^a   Rispal, Delphine ^a   Eltschinger, Sandra ^a   Robinson, Graham C ^a   Thore, Stéphane ^a,e,f   Aebersold, Ruedi ^d,g   Schaffitzel, Christiane ^b,h   Loewith, Robbie ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

^c Fondation ARC   (France)

^d ETH ZURICH   (Switzerland)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f INSERM U869   (France)

^g UNIVERSITY OF ZURICH   (Switzerland)

^h UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AVO1 PROTEIN; AVO3 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PROTEIN KINASE B; RAPAMYCIN; TOR2 PROTEIN; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT; CARRIER PROTEIN; CELL CYCLE PROTEIN; MULTIPROTEIN COMPLEX; PHOSPHATIDYLINOSITOL 3 KINASE; SACCHAROMYCES CEREVISIAE PROTEIN; TARGET OF RAPAMYCIN KINASE; TOR COMPLEX 2; TOR2 PROTEIN, S CEREVISIAE; TSC11 PROTEIN, S CEREVISIAE;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; ELECTRON MICROSCOPY; MASS SPECTROMETRY; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; BINDING SITE; BIOCATALYSIS; CELL CYCLE; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; METABOLISM; MUTATION; PROCEDURES; PROTEIN TERTIARY STRUCTURE; SACCHAROMYCES CEREVISIAE; ULTRASTRUCTURE; WESTERN BLOTTING;

EUKARYOTA;

ANTIFUNGAL AGENTS; BINDING SITES; BIOCATALYSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; DRUG RESISTANCE; MASS SPECTROMETRY; MICROSCOPY, ELECTRON; MULTIPROTEIN COMPLEXES; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN STRUCTURE, TERTIARY; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84937633778     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2015.04.031     Document Type: Article

References (55)

1. Adami A., García-Alvarez B., Arias-Palomo E., Barford D., Llorca O. Structure of TOR and its complex with KOG1. Mol. Cell 2007, 27:509-516.
2. Barbet N.C., Schneider U., Helliwell S.B., Stansfield I., Tuite M.F., Hall M.N. TOR controls translation initiation and early G1 progression in yeast. Mol. Biol. Cell 1996, 7:25-42.
3. Berchtold D., Walther T.C. TORC2 plasma membrane localization is essential for cell viability and restricted to a distinct domain. Mol. Biol. Cell 2009, 20:1565-1575.
4. Berchtold D., Piccolis M., Chiaruttini N., Riezman I., Riezman H., Roux A., Walther T.C., Loewith R. Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote sphingolipid synthesis. Nat. Cell Biol. 2012, 14:542-547.
5. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 2001, 26:657-664.
6. Cafferkey R., Young P.R., McLaughlin M.M., Bergsma D.J., Koltin Y., Sathe G.M., Faucette L., Eng W.K., Johnson R.K., Livi G.P. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol. Cell. Biol. 1993, 13:6012-6023.
7. Cornu M., Albert V., Hall M.N. mTOR in aging, metabolism, and cancer. Curr. Opin. Genet. Dev. 2013, 23:53-62.
8. de la Rosa-Trevín J.M., Otón J., Marabini R., Zaldívar A., Vargas J., Carazo J.M., Sorzano C.O. Xmipp 3.0: an improved software suite for image processing in electron microscopy. J. Struct. Biol. 2013, 184:321-328.
9. Elad N., Clare D.K., Saibil H.R., Orlova E.V. Detection and separation of heterogeneity in molecular complexes by statistical analysis of their two-dimensional projections. J. Struct. Biol. 2008, 162:108-120.
10. Fadri M., Daquinag A., Wang S., Xue T., Kunz J. The pleckstrin homology domain proteins Slm1 and Slm2 are required for actin cytoskeleton organization in yeast and bind phosphatidylinositol-4,5-bisphosphate and TORC2. Mol. Biol. Cell 2005, 16:1883-1900.
11. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J., Yonezawa K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002, 110:177-189.
12. Heitman J., Movva N.R., Hall M.N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991, 253:905-909.
13. Helliwell S.B., Wagner P., Kunz J., Deuter-Reinhard M., Henriquez R., Hall M.N. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol. Biol. Cell 1994, 5:105-118.
14. Jacinto E., Loewith R., Schmidt A., Lin S., Rüegg M.A., Hall A., Hall M.N. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 2004, 6:1122-1128.
15. Jain A., Arauz E., Aggarwal V., Ikon N., Chen J., Ha T. Stoichiometry and assembly of mTOR complexes revealed by single-molecule pulldown. Proc. Natl. Acad. Sci. USA 2014, 111:17833-17838.
16. Keith C.T., Schreiber S.L. PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 1995, 270:50-51.
17. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., Sabatini D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
18. Kim S.G., Hoffman G.R., Poulogiannis G., Buel G.R., Jang Y.J., Lee K.W., Kim B.Y., Erikson R.L., Cantley L.C., Choo A.Y., Blenis J. Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex. Mol. Cell 2013, 49:172-185.
19. Kliegman J.I., Fiedler D., Ryan C.J., Xu Y.F., Su X.Y., Thomas D., Caccese M.C., Cheng A., Shales M., Rabinowitz J.D., et al. Chemical genetics of rapamycin-insensitive TORC2 in S. cerevisiae. Cell Rep. 2013, 5:1725-1736.
20. Kunz J., Henriquez R., Schneider U., Deuter-Reinhard M., Movva N.R., Hall M.N. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 1993, 73:585-596.
21. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
22. Leitner A., Walzthoeni T., Aebersold R. Lysine-specific chemical cross-linking of protein complexes and identification of cross-linking sites using LC-MS/MS and the xQuest/xProphet software pipeline. Nat. Protoc. 2014, 9:120-137.
23. Lempiäinen H., Halazonetis T.D. Emerging common themes in regulation of PIKKs and PI3Ks. EMBO J. 2009, 28:3067-3073.
24. Liao H.C., Chen M.Y. Target of rapamycin complex 2 signals to downstream effector yeast protein kinase 2 (Ypk2) through adheres-voraciously-to-target-of-rapamycin-2 protein 1 (Avo1) in Saccharomyces cerevisiae. J. Biol. Chem. 2012, 287:6089-6099.
25. Liu P., Gan W., Inuzuka H., Lazorchak A.S., Gao D., Arojo O., Liu D., Wan L., Zhai B., Yu Y., et al. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nat. Cell Biol. 2013, 15:1340-1350.
26. Liu P., Wang Z., Wei W. Phosphorylation of Akt at the C-terminal tail triggers Akt activation. Cell Cycle 2014, 13:2162-2164.
27. Liu P.D., Begley M., Michowski W., Inuzuka H., Ginzberg M., Gao D.M., Tsou P.L., Gan W.J., Papa A., Kim B.M., et al. Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 2014, 508:541-545.
28. Loewith R., Hall M.N. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics 2011, 189:1177-1201.
29. Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J.L., Bonenfant D., Oppliger W., Jenoe P., Hall M.N. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 2002, 10:457-468.
30. Lu M., Wang J., Ives H.E., Pearce D. mSIN1 protein mediates SGK1 protein interaction with mTORC2 protein complex and is required for selective activation of the epithelial sodium channel. J. Biol. Chem. 2011, 286:30647-30654.
31. Ludtke S.J. 3-D structures of macromolecules using single-particle analysis in EMAN. Methods Mol. Biol. 2010, 673:157-173.
32. Merkley E.D., Rysavy S., Kahraman A., Hafen R.P., Daggett V., Adkins J.N. Distance restraints from crosslinking mass spectrometry: Mining a molecular dynamics simulation database to evaluate lysine-lysine distances. Protein Sci. 2014, 23:747-759.
33. Niles B.J., Mogri H., Hill A., Vlahakis A., Powers T. Plasma membrane recruitment and activation of the AGC kinase Ypk1 is mediated by target of rapamycin complex 2 (TORC2) and its effector proteins Slm1 and Slm2. Proc. Natl. Acad. Sci. USA 2012, 109:1536-1541.
34. Pan D., Matsuura Y. Structures of the pleckstrin homology domain of Saccharomyces cerevisiae Avo1 and its human orthologue Sin1, an essential subunit of TOR complex 2. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2012, 68:386-392.
35. Pracheil T., Thornton J., Liu Z. TORC2 signaling is antagonized by protein phosphatase 2A and the Far complex in Saccharomyces cerevisiae. Genetics 2012, 190:1325-1339.
36. Roelants F.M., Breslow D.K., Muir A., Weissman J.S., Thorner J. Protein kinase Ypk1 phosphorylates regulatory proteins Orm1 and Orm2 to control sphingolipid homeostasis in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 2011, 108:19222-19227.
37. Rosenthal P.B., Henderson R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J. Mol. Biol. 2003, 333:721-745.
38. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., Tempst P., Sabatini D.M. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 2004, 14:1296-1302.
39. Scheres S.H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 2012, 180:519-530.
40. Scheres S.H., Núñez-Ramírez R., Sorzano C.O., Carazo J.M., Marabini R. Image processing for electron microscopy single-particle analysis using XMIPP. Nat. Protoc. 2008, 3:977-990.
41. Shimada K., Filipuzzi I., Stahl M., Helliwell S.B., Studer C., Hoepfner D., Seeber A., Loewith R., Movva N.R., Gasser S.M. TORC2 signaling pathway guarantees genome stability in the face of DNA strand breaks. Mol. Cell 2013, 51:829-839.
42. Sibanda B.L., Chirgadze D.Y., Blundell T.L. Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats. Nature 2010, 463:118-121.
43. Sparks C.A., Guertin D.A. Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy. Oncogene 2010, 29:3733-3744.
44. Tarassov K., Messier V., Landry C.R., Radinovic S., Serna Molina M.M., Shames I., Malitskaya Y., Vogel J., Bussey H., Michnick S.W. An in vivo map of the yeast protein interactome. Science 2008, 320:1465-1470.
45. Uetz P., Giot L., Cagney G., Mansfield T.A., Judson R.S., Knight J.R., Lockshon D., Narayan V., Srinivasan M., Pochart P., et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000, 403:623-627.
46. Urban J., Soulard A., Huber A., Lippman S., Mukhopadhyay D., Deloche O., Wanke V., Anrather D., Ammerer G., Riezman H., et al. Sch9 is a major target of TORC1 in Saccharomyces cerevisiae. Mol. Cell 2007, 26:663-674.
47. van Heel M., Harauz G., Orlova E.V., Schmidt R., Schatz M. A new generation of the IMAGIC image processing system. J. Struct. Biol. 1996, 116:17-24.
48. Voss N.R., Yoshioka C.K., Radermacher M., Potter C.S., Carragher B. DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy. J. Struct. Biol. 2009, 166:205-213.
49. Walzthoeni T., Claassen M., Leitner A., Herzog F., Bohn S., Förster F., Beck M., Aebersold R. False discovery rate estimation for cross-linked peptides identified by mass spectrometry. Nat. Methods 2012, 9:901-903.
50. Wedaman K.P., Reinke A., Anderson S., Yates J., McCaffery J.M., Powers T. Tor kinases are in distinct membrane-associated protein complexes in Saccharomyces cerevisiae. Mol. Biol. Cell 2003, 14:1204-1220.
51. Wullschleger S., Loewith R., Oppliger W., Hall M.N. Molecular organization of target of rapamycin complex 2. J. Biol. Chem. 2005, 280:30697-30704.
52. Yang H., Rudge D.G., Koos J.D., Vaidialingam B., Yang H.J., Pavletich N.P. mTOR kinase structure, mechanism and regulation. Nature 2013, 497:217-223.
53. Yip C.K., Murata K., Walz T., Sabatini D.M., Kang S.A. Structure of the human mTOR complex I and its implications for rapamycin inhibition. Mol. Cell 2010, 38:768-774.
54. Zinzalla V., Sturgill T.W., Hall M.N. TOR Complexes: Composition, Structure and Phosphorylation 2010, Volume 28. Academic Press, London, San Diego.
55. Zinzalla V., Stracka D., Oppliger W., Hall M.N. Activation of mTORC2 by association with the ribosome. Cell 2011, 144:757-768.